Mentice Q1: Growth within reach of long-term target - Redeye

Balanced regional growth with broad-based support from the Medical Device segment. Mentice is in the process of streamlining the organisation, which is also triggering some temporary pressure on reported EBITDA. We regard yesterday’s share price reaction based on Mentice’s broad customer base and a well-established portfolio of solutions.

Länk till analysen i sin helhet: https://www.redeye.se/research/1106557/mentice-q1-growth-within-reach-of-long-term-target?utm_source=finwire&utm_medium=RSS